Optimization of the two‐stage group sequential three‐arm gold‐standard design for non‐inferiority trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimization of the two‐stage group sequential three‐arm gold‐standard design for non‐inferiority trials

Published:2022-12-28 Issue:4 Volume:42 Page:536-558
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Meis Jan¹^ORCID,Pilz Maximilian¹^ORCID,Herrmann Carolin²^ORCID,Bokelmann Björn²^ORCID,Rauch Geraldine²^ORCID,Kieser Meinhard¹^ORCID

Affiliation:

1. Institute of Medical Biometry University of Heidelberg Heidelberg Germany

2. Charité ‐ Universitätsmedizin Berlin Corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin, Institute of Biometry and Clinical Epidemiology Berlin Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.9630

Reference36 articles.

1. Committee for medicinal products for human use (CHMP) guideline on the choice of the non-inferiority margin

2. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo

3. Planning and analysis of three-arm non-inferiority trials with binary endpoints

4. Assessing non-inferiority of a new treatment in a three-arm trial in the presence of heteroscedasticity

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP